Roberta D'Arrigo

Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort.

Francesca Ceccherini-Silberstein, F. Ceccherini‐Silberstein, P. Narciso, 2004, The Journal of infectious diseases.

Molecular Epidemiology: HIV-1 and HCV sequences from Libyan outbreak

Tulio de Oliveira, Andrew Rambaut, Oliver G. Pybus, 2006, Nature.

Identification and Structural Characterization of Novel Genetic Elements in the HIV-1 V3 Loop Regulating Coreceptor Usage

Stefano Alcaro, Giorgio Palù, Anna Artese, 2011, Antiviral therapy.

Characterization and structural analysis of HIV-1 integrase conservation.

Francesca Ceccherini-Silberstein, F. Ceccherini‐Silberstein, A. Antinori, 2009, AIDS reviews.

Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment.

Stefano Bonora, Valentina Svicher, P. Narciso, 2006, The Journal of antimicrobial chemotherapy.

Additional Mutations in HIV-1 Reverse Transcriptase are Involved in the Highly Ordered Regulation of NRTI Resistance

Niko Beerenwinkel, Federico Gago, Tobias Sing, 2005 .

HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.

Jeroen Aerssens, Valentina Svicher, Loredana Sarmati, 2011, Antiviral research.